Royal Bank of Canada’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-80
| Closed | -$1K | – | 7868 |
|
|
2022
Q4 | $1K | Sell |
80
-1,049
| -93% | -$14.5K | ﹤0.01% | 7150 |
|
|
2022
Q3 | $10K | Buy |
1,129
+329
| +41% | +$2.53K | ﹤0.01% | 6448 |
|
|
2022
Q2 | $5K | Hold |
800
| – | – | ﹤0.01% | 6695 |
|
|
2022
Q1 | $4K | Hold |
800
| – | – | ﹤0.01% | 7363 |
|
|
2021
Q4 | $4K | Hold |
800
| – | – | ﹤0.01% | 7310 |
|
|
2021
Q3 | $5K | Sell |
800
-2,876
| -78% | -$17.2K | ﹤0.01% | 7177 |
|
|
2021
Q2 | $24K | Buy |
3,676
+1,006
| +38% | +$6.94K | ﹤0.01% | 6491 |
|
|
2021
Q1 | $20K | Sell |
2,670
-873
| -25% | -$7.53K | ﹤0.01% | 6437 |
|
|
2020
Q4 | $20K | Buy |
3,543
+2,735
| +338% | +$15.7K | ﹤0.01% | 6080 |
|
|
2020
Q3 | $5K | Buy |
808
+8
| +1% | +$40 | ﹤0.01% | 6159 |
|
|
2020
Q2 | $4K | Hold |
800
| – | – | ﹤0.01% | 6146 |
|
|
2020
Q1 | $3K | Hold |
800
| – | – | ﹤0.01% | 6259 |
|
|
2019
Q4 | $5K | Hold |
800
| – | – | ﹤0.01% | 6395 |
|
|
2019
Q3 | $7K | Sell |
800
-270
| -25% | -$2.01K | ﹤0.01% | 5928 |
|
|
2019
Q2 | $7K | Buy |
1,070
+270
| +34% | +$2.31K | ﹤0.01% | 6199 |
|
|
2019
Q1 | $7K | Sell |
800
-115
| -13% | -$1.19K | ﹤0.01% | 6167 |
|
|
2018
Q4 | $15K | Sell |
915
-120
| -12% | -$2.64K | ﹤0.01% | 5718 |
|
|
2018
Q3 | $34K | Buy |
1,035
+235
| +29% | +$6.04K | ﹤0.01% | 5423 |
|
|
2018
Q2 | $18K | Buy |
+800
| New | +$19K | ﹤0.01% | 5593 |
|
|
2015
Q4 | – | Sell |
-24
| Closed | – | – | 6951 |
|
|
2015
Q3 | $0 | Hold |
24
| – | – | ﹤0.01% | 6867 |
|
|
2015
Q2 | $0 | Buy |
+24
| New | +$432 | ﹤0.01% | 6800 |
|
|
2013
Q4 | – | Sell |
-2,220
| Closed | -$45K | – | 6264 |
|
|
2013
Q3 | $45K | Sell |
2,220
-1,280
| -37% | -$29.3K | ﹤0.01% | 4860 |
|
|
2013
Q2 | $88K | Buy |
+3,500
| New | +$150K | ﹤0.01% | 4380 |
|
Royal Bank of Canada's AVEO Position: Q1 2023 in Review
Royal Bank of Canada sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 80 shares — an estimated $1K sold.
Royal Bank of Canada first reported a position in AVEO in Q2 2013 and held it in 23 quarters. The position peaked at $88K in Q2 2013. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.
- Royal Bank of Canada reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Royal Bank of Canada sold 80 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $1K.
- Royal Bank of Canada first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 23 quarters.
- Royal Bank of Canada's AVEO Pharmaceuticals, Inc. position peaked at $88K in Q2 2013.
- 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.
Based on Royal Bank of Canada's 13F filing for Q1 2023, filed 15 May 2023.